FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3123453085> ?p ?o ?g. }

• W3123453085 abstract "Many studies have shown that the efficacy and risk of side effects of drug treatment is influenced by genetic variants. Evidence based guidelines are essential for implementing pharmacogenetic knowledge in daily clinical practice to optimize pharmacotherapy of individual patients. A literature search was performed to select committees developing guidelines with recommendations being published in English. The Dutch Pharmacogenetics Working Group (DPWG), the Clinical Pharmacogenetics Implementation Consortium (CPIC), the Canadian Pharmacogenomics Network for Drug Safety (CPNDS), and the French National Network (Réseau) of Pharmacogenetics (RNPGx) were selected. Their guidelines were compared with regard to the methodology of development, translation of genotypes to predicted phenotypes, pharmacotherapeutic recommendations and recommendations on genotyping. A detailed overview of all recommendations for gene-drug combinations is given. The committees have similar methodologies of guideline development. However, the objectives differed at the start of their projects, which have led to unique profiles and strengths of their guidelines. DPWG and CPIC have a main focus on pharmacotherapeutic recommendations for a large number of drugs in combination with a patient’s genotype or predicted phenotype. DPWG, CPNDS and RNPGx also recommend on performing genetic testing in daily clinical practice, with RNPGx even describing specific clinical settings or medical conditions for which genotyping is recommended. Discordances exist, however committees also initiated harmonizing projects. The outcome of a consensus project was to rename “extensive metabolizer (EM)” to “normal metabolizer (NM)”. It was decided to translate a CYP2D6 genotype with one nonfunctional allele (activity score 1.0) into the predicted phenotype of intermediate metabolizer (IM). Differences in recommendations are the result of the methodologies used, such as assessment of dose adjustments of tricyclic antidepressants. In some cases, indication or dose specific recommendations are given for example for clopidogrel, codeine, irinotecan. The following drugs have recommendations on genetic testing with the highest level: abacavir (HLA), clopidogrel (CYP2C19), fluoropyrimidines (DPYD), thiopurines (TPMT), irinotecan (UGT1A1), codeine (CYP2D6), and cisplatin (TPMT). The guidelines cover many drugs and genes, genotypes, or predicted phenotypes. Because of this and their unique features, considering the totality of guidelines are of added value. In conclusion, many evidence based pharmacogenetics guidelines with clear recommendations are available for clinical decision making by healthcare professionals, patients and other stakeholders." @default.
• W3123453085 created "2021-02-01" @default.
• W3123453085 creator A5014475207 @default.
• W3123453085 creator A5019268165 @default.
• W3123453085 creator A5034588497 @default.
• W3123453085 creator A5084362543 @default.
• W3123453085 date "2021-01-25" @default.
• W3123453085 modified "2023-10-09" @default.
• W3123453085 title "Pharmacogenetics Guidelines: Overview and Comparison of the DPWG, CPIC, CPNDS, and RNPGx Guidelines" @default.
• W3123453085 cites W1968604782 @default.
• W3123453085 cites W1994175864 @default.
• W3123453085 cites W2026995360 @default.
• W3123453085 cites W2029855681 @default.
• W3123453085 cites W2030352776 @default.
• W3123453085 cites W2033139608 @default.
• W3123453085 cites W2053440509 @default.
• W3123453085 cites W2059300085 @default.
• W3123453085 cites W2060570337 @default.
• W3123453085 cites W2067117895 @default.
• W3123453085 cites W2091212941 @default.
• W3123453085 cites W2108182085 @default.
• W3123453085 cites W2116617956 @default.
• W3123453085 cites W2127752492 @default.
• W3123453085 cites W2130673730 @default.
• W3123453085 cites W2138509705 @default.
• W3123453085 cites W2161620765 @default.
• W3123453085 cites W2162251320 @default.
• W3123453085 cites W2167407582 @default.
• W3123453085 cites W2171345479 @default.
• W3123453085 cites W2210812892 @default.
• W3123453085 cites W2335023411 @default.
• W3123453085 cites W2342699699 @default.
• W3123453085 cites W2385169442 @default.
• W3123453085 cites W2502485509 @default.
• W3123453085 cites W2510653789 @default.
• W3123453085 cites W2561831579 @default.
• W3123453085 cites W2562052809 @default.
• W3123453085 cites W2562778159 @default.
• W3123453085 cites W2563534429 @default.
• W3123453085 cites W2580367396 @default.
• W3123453085 cites W2581311384 @default.
• W3123453085 cites W2581425056 @default.
• W3123453085 cites W2582497016 @default.
• W3123453085 cites W2583005369 @default.
• W3123453085 cites W2588108371 @default.
• W3123453085 cites W2763273027 @default.
• W3123453085 cites W2770862842 @default.
• W3123453085 cites W2775639388 @default.
• W3123453085 cites W2788695304 @default.
• W3123453085 cites W2790114875 @default.
• W3123453085 cites W2792046032 @default.
• W3123453085 cites W2792944991 @default.
• W3123453085 cites W2794417831 @default.
• W3123453085 cites W2811318782 @default.
• W3123453085 cites W2899955386 @default.
• W3123453085 cites W2900478530 @default.
• W3123453085 cites W2900673338 @default.
• W3123453085 cites W2903311717 @default.
• W3123453085 cites W2917080169 @default.
• W3123453085 cites W2937367049 @default.
• W3123453085 cites W2971100262 @default.
• W3123453085 cites W2971992346 @default.
• W3123453085 cites W2981329862 @default.
• W3123453085 cites W2990707203 @default.
• W3123453085 cites W3012167797 @default.
• W3123453085 cites W3017267835 @default.
• W3123453085 cites W4236035733 @default.
• W3123453085 cites W4237758853 @default.
• W3123453085 doi "https://doi.org/10.3389/fphar.2020.595219" @default.
• W3123453085 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7868558" @default.
• W3123453085 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33568995" @default.
• W3123453085 hasPublicationYear "2021" @default.
• W3123453085 type Work @default.
• W3123453085 sameAs 3123453085 @default.
• W3123453085 citedByCount "76" @default.
• W3123453085 countsByYear W31234530852021 @default.
• W3123453085 countsByYear W31234530852022 @default.
• W3123453085 countsByYear W31234530852023 @default.
• W3123453085 crossrefType "journal-article" @default.
• W3123453085 hasAuthorship W3123453085A5014475207 @default.
• W3123453085 hasAuthorship W3123453085A5019268165 @default.
• W3123453085 hasAuthorship W3123453085A5034588497 @default.
• W3123453085 hasAuthorship W3123453085A5084362543 @default.
• W3123453085 hasBestOaLocation W31234530851 @default.
• W3123453085 hasConcept C104317684 @default.
• W3123453085 hasConcept C135763542 @default.
• W3123453085 hasConcept C142724271 @default.
• W3123453085 hasConcept C163763905 @default.
• W3123453085 hasConcept C170734499 @default.
• W3123453085 hasConcept C2779473830 @default.
• W3123453085 hasConcept C2779974597 @default.
• W3123453085 hasConcept C2780182762 @default.
• W3123453085 hasConcept C31467283 @default.
• W3123453085 hasConcept C512399662 @default.
• W3123453085 hasConcept C54355233 @default.
• W3123453085 hasConcept C55493867 @default.
• W3123453085 hasConcept C55775858 @default.
• W3123453085 hasConcept C71924100 @default.
• W3123453085 hasConcept C86803240 @default.
• W3123453085 hasConcept C98274493 @default.

• next